Cost and impact of a bioburden incident

A guest blog by David Westman, Global Product Marketing Manager BioProcess Chromatography Resins at GE Healthcare Manufacturing biologicals is tricky. A major concern is the risk of microbial contamination, jeopardizing product safety and causing high costs. But there are solutions for decreasing the risks. Making monoclonal antibody (mAb) drugs? Safety first In releasing a biomedicine, … Continue reading Cost and impact of a bioburden incident